Apollomics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APLM research report →
Companywww.apollomicsinc.com
Apollomics, Inc. , a biotechnology company, engages in the discovery and development of oncology therapies to address unmet medical needs in California, Hangzhou, Shanghai, China, and Australia. It develops APL-101 (Vebreltinib), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors; APL-102 is an oral active, small molecule multiple tyrosine kinase inhibitor for liver cancer, breast cancer, and esophageal cancer; and APL-122, a tumor inhibitor candidate to treat cancers within the brain.
- CEO
- Hung-Wen Chen
- IPO
- 2021
- Employees
- 13
- HQ
- Foster City, CA, US
Price Chart
Valuation
- Market Cap
- $15.27M
- P/E
- -0.53
- P/S
- 1.80
- P/B
- -1.83
- EV/EBITDA
- -1.33
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- -111.45%
- Net Margin
- -128.69%
- ROE
- 288.40%
- ROIC
- -1586.77%
Growth & Income
- Revenue
- $8.50M · 4192.93%
- Net Income
- $-10,939,000 · 79.69%
- EPS
- $-7.57 · 85.66%
- Op Income
- $-9,473,000
- FCF YoY
- 63.96%
Performance & Tape
- 52W High
- $42.12
- 52W Low
- $3.66
- 50D MA
- $15.71
- 200D MA
- $16.12
- Beta
- 1.52
- Avg Volume
- 7.30K
Get TickerSpark's AI analysis on APLM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 17, 26 | Huang Ya-Chi | other | 500 |
| May 17, 26 | Huang Ya-Chi | other | 500 |
| Mar 18, 26 | CHEN HONG-JUNG | other | 0 |
| Mar 31, 26 | CHEN HONG-JUNG | other | 2,290 |
| Mar 31, 26 | LIN PETER KUAN-HOW | other | 3,582 |
| Mar 18, 26 | Jan Chen-Huan | other | 0 |
| Mar 18, 26 | TSAI HSIEN-SHU | other | 0 |
| Mar 18, 26 | LIN PETER KUAN-HOW | other | 0 |
| Mar 19, 26 | Chen Hung-Wen | other | 0 |
| Mar 19, 26 | Chen Hung-Wen | other | 0 |
Our APLM Coverage
We haven't published any research on APLM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate APLM Report →